Novo Nordisk A/S

PNK: NONOF · Real-Time Price · USD
66.75
-0.65 (-0.96%)
At close: May 01, 2025, 3:59 PM

Novo Nordisk A/S Revenue

Novo Nordisk A/S reported an annual revenue of $290.4B, reflecting a 25.03% growth. For the quarter ending December 31, 2024, Novo Nordisk A/S generated $85.68B in revenue.
Revenue (ttm)
$290.4B
Revenue Growth
25.03%
Price / Sales Ratio
9.49
Revenue / Employee
$3.81M
Employees
76,302
Market Cap
296.31B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 290.4B +25.03%
Dec 31, 2023 232.26B +31.26%
Dec 31, 2022 176.95B +25.68%
Dec 31, 2021 140.8B +10.91%
Dec 31, 2020 126.95B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.